Benserazide Completed Phase 3 Trials for Parkinson's Disease (PD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01227655Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients.
NCT01568073Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients With Wearing-off Phenomenon